Presentation on the use of injectable buprenophrine for the treatment of Opioid Use Disorder (OUD) in patients using Highly Potent Synthetic Opioids (HPSO)
Goals & Objectives:
At the conclusion of this activity participants should be able to:
- Review the data supporting the use of injectable extended-release buprenorphine treatment for opioid use disorder.
- Identify special risks that fentanyl use presents and the possible role of injectable extended release buprenorphine treatment.
- Discuss the role of extended-release injectable buprenorphine in the treatment of OUD patients using fentanyl.